These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 8468440

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of moclobemide on nocturnal sleep of depressed patients.
    Monti JM, Alterwain P, Monti D.
    J Affect Disord; 1990 Nov; 20(3):201-8. PubMed ID: 2148341
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Moclobemide--placebo-controlled trials.
    Silverstone T.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
    [Abstract] [Full Text] [Related]

  • 9. The role of moclobemide in endogenous depression: a survey of recent data.
    Woggon B.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):137-9. PubMed ID: 8468434
    [Abstract] [Full Text] [Related]

  • 10. Effect of chronic phenelzine treatment on REM sleep: report of three patients.
    Landolt HP, de Boer LP.
    Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S63-7. PubMed ID: 11682276
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R, Márquez CA, Traballi CA, Portes N.
    Acta Psychiatr Scand Suppl; 1990 Nov; 360():54-6. PubMed ID: 2123367
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M, Nardi AE, Figueira IL, Stabl M.
    Acta Psychiatr Scand Suppl; 1990 Nov; 360():24-8. PubMed ID: 2123366
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.
    Lonnqvist J, Sintonen H, Syvälahti E, Appelberg B, Koskinen T, Mannikko T, Mehtonen OP, Naarala M, Sihvo S, Auvinen J.
    Acta Psychiatr Scand; 1994 Jun; 89(6):363-9. PubMed ID: 8085464
    [Abstract] [Full Text] [Related]

  • 20. Interaction between moclobemide and oral tyramine in depressed patients.
    Burgess CD, Mellsop GW.
    Fundam Clin Pharmacol; 1989 Jun; 3(1):47-52. PubMed ID: 2714732
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.